Arriaga-Pizano L, Ramírez-Ramírez D, Prieto-Chávez J, Pelayo R, Ruiz-Argüelles A

Idioma: Español
Referencias bibliográficas: 23
Paginas: 20-29
Archivo PDF: 217.20 Kb.

RESUMEN

En 2005 se publicaron recomendaciones para la tipificación de hemopatías malignas en Latinoamérica. Se consideró necesario realizar una reunión nacional para actualizarlas. Se convocaron y reunieron 95 profesionales expertos en el tema para analizar y contrastar alternativas y llegar a un consenso. Se alcanzaron opiniones de consenso en lo relativo a indicaciones, tipos y manejo de muestras, anticuerpos, nomenclatura e informe de resultados para el diagnóstico y seguimiento de las leucemias agudas. Las recomendaciones se describen en este artículo y se hace hincapié en la necesidad de que los laboratorios nacionales se apeguen a ellas.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Pérez-Saldívar ML, Fajardo-Gutiérrez A, Bernáldez-Ríos R, Martínez-Ávalos A, Medina-Sanson A, Espinosa-Hernández L, et al. Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer. 2011;11:355.

2. Xu H, Cheng C, Devidas M, Pei D, Fan Y, Yang W, et al. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol. 2012;30:751-757.

3. Vilchis-Ordoñez A, Dorantes-Acosta E, Vadillo E, López-Martínez B, Pelayo R. Early hematopoietic differentiation in acute lymphoblastic leukemia: the interplay between leukemia-initiating cells and abnormal bone marrow microenvironment. En: Mejía-Aranguré JA , editor. Etiology of acute leukemias in children. México: Springer; 2016.

4. Dorantes-Acosta E, Pelayo R. Lineage switching in acute leukemias: a consequence of stem cell plasticity? Bone Marrow Res. 2012;2012:406796.

5. Xie Y, Davies SM, Xiang Y, Robison LL, Ross JA. Trends in leukemia incidence and survival in the United States (1973-1998). Cancer. 2003; 97:2229-2235.

6. Mejía-Aranguré JM, Núñez-Enríquez JC, Fajardo-Gutiérrez A, Rodriguez- Zepeda MD, Martin-Trejo JA, Duarte-Rodriguez DA, et al. Descriptive epidemiology of children with acute myeloid leukemia residing in Mexico City: a report from the Mexican Inter-Institutional Group for Identifying Childhood Leukemia Causes. Gac Med Mex. 2016;152:66-77.

7. Balandrán JC, Vadillo E, Dozal D, Reyes-López A, Sandoval-Cabrera A, Laffont-Ortiz MD, et al. Analysis of normal hematopoietic stem and progenitor cell contents in childhood acute leukemia bone marrow. Arch Med Res. 2016;47:629-643.

8. Izraeli S. Similar yet different. Blood. 2010;116:1019-20.

9. Juárez-Velázquez R, Reyes-León A, Salas-Labadía C, Rivera-Luna R, Velasco-Hidalgo L, López-Hernández G, et al. Significance of CASP8AP2 and H2AFZ expression in survival and risk of relapse in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2014;55:2305-2311.

10. Pui CH, Rubnitz JE, Hancock ML, Downing JR, Raimondi SC, Rivera GK, et al. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia. J Clin Oncol. 1998;16(12):3768-3773.

11. Rubnitz JE, Onciu M, Pounds S, Shurtleff S, Cao X, Raimondi SC, et al. Acute mixed lineage leukemia in children: the experience of St Jude Children’s Research Hospital. Blood. 2009;113:5083-5089.

12. Meijerink JP, Den-Boer ML, Pieters R. New genetic abnormalities and treatment response in acute lymphoblastic leukemia. Semin Hematol. 2009;46:16-23.

13. Kakarala M, Wicha MS. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol. 2008;26 2813-2820.

14. Rajendran P, Dalerba, P. Theoretical and experimental foundations of the “cancer stem cell” model. En: Rajasekhar V, editor. Cancer stem cells. EE. UU.: Wiley-Blackwell; 2014.

15. Chávez-González A, Avilés-Vázquez S, Moreno-Lorenzana D, Mayani H. Hematopoietic stem cells in chronic myeloid leukemia. En: Alimoghaddam K, editor. Stem cell biology in normal life and diseases. Croacia: IntechOpen; 2013.

16. Chung SS, Park, CY. Acute myeloid leukemia cells-updates and controversies. En: Rajasekhar V (editor). Cancer stem cells. EE. UU.: Wiley- Blackwell; 2014.

17. Raff T, Bruggermann, M. Leukemia-initiating cells in acute lymphoblastic leukemia. En: Rajasekhar V (editor). Cancer stem cells. EE. UU.: Wiley- Blackwell; 2014.

18. Balandrán JC, Purizaca J, Enciso J, Dozal D, Sandoval A, Jiménez-Hernández E, et al. Pro-inflammatory-related loss of CXCL12 niche promotes acute lymphoblastic leukemic progression at the expense of normal lymphopoiesis. Front Immunol. 2016;7:666.

19. Ruiz-Argüelles A, Duque RE, Orfao A. Report on the first Latin American Consensus Conference for Flow Cytometric Immunophenotyping of Leukemia. Cytometry. 1998;34:39-42.

20. Ruiz-Argüelles A, Rivadeneyra-Espinoza L, Duque RE, Orfao A, Latin American Consensus Conference. Report on the second Latin American Consensus Conference for flow cytometric immunophenotyping of hematological malignancies. Cytometry B Clin Cytom. 2006;70:39-44.

21. EuroFlow. Standard Operating Protocol (SOP) for Bulk Lysis for MRD panels (versión 1.1) 2014. Disponible en http://medtechtrading.ch/data/ documents/BulkLysisProtocol.pdf

22. Haydu JE, Ferrando AA. Early T-cell precursor acute lymphoblastic leukaemia. Curr Opin Hematol. 2013;20:369-373.

23. Jain N, Roberts KG, Jabbour E, Patel K, Eterovic AK, Chen K, et al. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood. 2017;129 572-581.